Amgen to acquire Rodeo Therapeutics in $721m worth deal

Amgen has agreed to acquire Rodeo Therapeutics, a Seattle-based biopharma company, in a deal worth up to $721 million. Rodeo Therapeutics is engaged in developing ... Read More